FDA’s Oncology Center of Excellence published a Request for Applications for projects aimed at developing and implementing new approaches to support drug development for ultra-rare pediatric and adult cancers.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
